Author:
Mehdipour Masoumeh,Gholizadeh Narges,Sadrzadeh-Afshar Maryam-Sadat,Hematpoor Nasim,Kalaee Parisa,Hakemi Vala Mojdeh,Namazi Zahra, , , , , , ,
Reference24 articles.
1. Marchetti O, Bille J, Fluckiger U, Eggimann P, Ruef C, Garbino J, et al. Epidemiology of candidemia in Swiss tertiary care hospitals: sec-ular trends, 1991-2000. Clin Infect Dis. 2004 Feb 1; 38 (3):311-20.
2. Mehdipour M, Hakemi Vala M,
Sadrzadeh-Afshar M, Gholizadeh N. In vitro
antifungal effect of cinnamon extract on candida species. Caspian J Dent Res. 2018 Sep;7(2):49-53.
3. Bodey GP, Mardani M, Hanna HA, Boktour M, Abbas J, Girgawy E, et al. The epidemiology of Candida glabrata and Candida albicans
fungemia in immunocompromised patients with cancer. Am J Med. 2002 Apr 1;112(5):380-5.
4. Panackal AA, Gribskov JL, Staab JF, Kirby KA, Rinaldi M, Marr KA. Clinical significance of azole antifungal drug cross-resistance in Candida
glabrata. J Clin Microbiol. 2006 May; 44(5):1740-3.
5. Bethea EK, Carver BJ, Montedonico AE,
Reynolds TB. The inositol regulon controls
viability in Candida glabrata. Microbiology. 2010 Feb;156(Pt 2):452-62.